GEGustavo Escobar

Gustavo Escobar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gustavo Escobar has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Synthesis and Evaluation of Trypanocidal Activity of Chromane-Type Compounds and Acetophenones

    by Luis A. González, Sara Robledo, Yulieth Upegui, Gustavo Escobar, Wiston Quiñones

    American trypanosomiasis (Chagas disease) caused by the Trypanosoma cruzi parasite, is a severe health problem in different regions of Latin America and is currently reported to be spreading to Europe, North America, Japan, and Australia, due to the migration of populations from South and Central America. At present, there is no vaccine available and chemotherapeutic options are reduced to nifurtimox and benznidazole. Therefore, the discovery of new molecules is urgently needed to initiate the drug development process. Some acetophenones and chalcones, as well as chromane-type substances, such as chromones and flavones, are natural products that have been studied as trypanocides, but the relationships between structure and activity are not yet fully understood. In this work, 26 compounds were synthesized to determine the effect of hydroxyl and isoprenyl substituents on trypanocide activity. One of the compounds showed interesting activity against a resistant strain of T. cruzi, with a half effective concentration of 18.3 µM ± 1.1 and an index of selectivity > 10.9.


  • Synthesis, Cytotoxicity, and Leishmanicidal Evaluation of Ent‐beyerene and Ent‐kaurene Derivatives

    by Jilmar Andres Murillo, Fernando Echeverri, Winston Quinones, Fernando Torres, Laura Isaza, Sara Maria Robledo, Tatiana Pineda, Horacio F. Olivo, Gustavo Adolfo Escobar

    Cutaneous leishmaniasis (CL) is an infectious disease endemic of tropical and subtropical countries, for which current pharmacologic treatments have serious drawbacks. Therefore, new and improved medical treatments are required. On the other side, natural products have been a valuable source of bioactive molecules, but unlike other products of natural origin, diterpenoids are molecules with only a few studies as antiparasitic drugs. Continuing our work on syntheses of beyerenes, and focusing on obtaining more compounds with antiparasitic activity, we describe in this work the syntheses and activity of several ent‐beyerene and ent‐kaurene type of compounds against CL, and also their toxicity. Utilizing classical reactions such as Grignard, Mitsunobu, and Williamson, among others, it was possible to modify rings A and D of ent‐beyerenes, specifically C‐19 on ring A, and C‐15 and C‐16 on ring D. A total of 40 new compounds were obtained, 21 of them being active against Leishmania (Viannia) braziliensis with median effective concentration (EC50) values less than 25.0 μg/mL and of these with EC50 values ranging from 1.8 to 7.1 μg/mL and Selectivity Index (SI) varying from 1.1 to 5.1. All compounds showed to be highly cytotoxic at concentrations less than 100 μg/mL, except compound 37 that was cytotoxic at 279.7 μg/mL and moderately active against L. braziliensis (EC50=33.5 μg/mL and an SI of 8.4. All active compounds were ent‐beyerene type.


  • Open Access

    Preparation of Rotenone Derivatives and in Vitro Analysis of Their Antimalarial, Antileishmanial and Selective Cytotoxic Activities

    by Yulieth Upegui, Juan F. Gil, Wiston Quiñones, Fernando Torres, Gustavo Escobar, Sara M. Robledo, Fernando Echeverri

    Six derivatives of the known biopesticide rotenone were prepared by several chemical transformations. Rotenone and its derivatives showed differential in vitro antiparasitic activity and selective cytotoxicity. In general, compounds were more active against Plasmodium falciparum than Leishmania panamensis. Rotenone had an EC50 of 19.0 µM against P. falciparum, and 127.2 µM against L. panamensis. Although chemical transformation does not improve its biological profile against P. falciparum, three of its derivatives showed a significant level of action within an adequate range of activity with EC50 values < 50.0 µM. This antiplasmodial activity was not due to red blood cell hemolysis, since LC50 was >>400 µM. On the other hand, all derivatives displayed a non-specific cytotoxicity on several cell lines and primary human cell cultures.